又一名人因癌去世!肿瘤患者该不该化疗,北京医生说了大实话!

2018-11-13 张晓东 三甲传真

媒体报道,台湾文化名人曾仕强于11日在台湾辞世,享年84岁。此前他曾在央视百家讲坛中讲解《易经的奥秘》等作品。2016年,他被检查出癌症,他说:“经不起化疗的折腾,那怎么办呢?那只好快快乐乐的面对它!既不怨天尤人,也不在那里叫苦连天”。


媒体报道,台湾文化名人曾仕强于11日在台湾辞世,享年84岁。此前他曾在央视百家讲坛中讲解《易经的奥秘》等作品。2016年,他被检查出癌症,他说:“经不起化疗的折腾,那怎么办呢?那只好快快乐乐的面对它!既不怨天尤人,也不在那里叫苦连天”。

首先为曾先生面对疾病乐观的态度点赞,特别是“既不怨天尤人,也不叫苦连连”!生老病死很多时候人类不能左右,人生要乐观面对的不只是疾病!

但看到这样的报道,作为肿瘤科医生我又不得不说“太误导百姓”!

我早就说过,每个人患癌症的情况都不同;化疗也不是折腾,折腾的是本不该治疗的”治疗”!

我早就说过,年过80岁患癌太正常了,原本癌症就是老年病!

我早就说过,患者是否需要治疗和怎么治疗是医生的事情。

我早就说过,患者可以因为各种原因不接受治疗,唯独不要因为被误导而放弃治疗!

说实话,曾老先生之所以能“面带微笑”还是疾病本身没有给他带来太多困扰,否则肠梗阻、大出血、无法进食……恐怕也面带不了微笑!

这样的微博文传递给患者的信息就是化疗是折腾!我告诉大家,化疗的作用有二,一是让肿瘤缩小为治愈创造机会;二是改善生活质量!这第二条是写进各国治疗指南的,晚期患者主要受益于化疗改善生活质量,前提是化疗要有效,以癌为例,联合化疗患者有效率35-45%,也就是说有55-65%的患者在对大家说“化疗无效,是在折腾,在加速死亡”,而化疗有效的35-45%的患者在偷着乐,这就是中国现状!

患者死亡不是化疗所致,是化疗无效使疾病进展不能控制所致!

如果患者自己不是因为被误导而放弃治疗我坚决尊重和支持,就怕先是拒绝治疗,吃各种“神药”,之后又找医生“拼命”要求化放疗,这是临床最头疼的事情。肿瘤治疗真的是“过了这村儿没这店儿”!

癌症也不能一概而论,不同的癌种对化疗的反应和预后都不同,例如相对癌,乳腺癌的化疗疗效好,生存也长!如果人的一生一定要患一种癌,所有的医生都会选择甲状腺癌。可见都是“癌”,但千差万别!

相同的癌也不能一概而论,早期癌相对晚期癌预后太好了,例如胃癌,早期治愈率高达90%以上,晚期胃癌治愈率不足5%。

所以您说,癌症患者到底治与不治听谁的?当然是医生根据患者的癌种、分期、化疗敏感性、年龄、身体状况、生活质量、是否存在其他疾病等等综合考虑决定!

每一位癌症患者在初诊初治时,医生都会权衡各种因素做出综合判断,有时都不是一位医生可以决定的,要经过多学科综合讨论决定如何治疗患者最获益,获益到什么程度,可能的风险是什么,并且充分与患者和家属沟通!

患癌后应该积极、乐观的面对,是否治疗和怎么治疗要听医生的客观、科学的分析判断。

化疗既不像传说的那么恐怖,也没有那么神奇,之所以百年考验仍然延续下来的治疗方法一定有它存在的理由!现代的肿瘤化疗药物的改进,有很多辅助用药支持,大大降低了化疗副反应,患者基本都可以耐受不良反应,特别是老年人,只要合理的用药,耐受性和疗效都比年轻患者好!

如果这段新闻稿让我写会这样:台湾文化名人曾仕强先生于2018.11.11日在台湾辞世,享年84岁。2016年他被检查出癌症,考虑多方面的因素老先生没有做治疗,他以乐观积极的心态面对疾病,既不怨天尤人,也不叫苦连连,走完了自己光辉的一生,完美谢幕!

说了这么多,怎么叫不折腾哪?在有机会和有希望控制肿瘤时积极配合医生做治疗;在治疗无效或身体不能耐受治疗时,微笑面对每一天,不折腾!

最后再次由衷地提醒百姓,按时做早癌筛查是抗癌最有效的措施!早诊早治是免除化疗之苦的唯一!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
    2019-06-08 若水134
  2. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
    2018-11-14 kafei

    了解一下谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
    2018-11-13 医者仁心5538

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1740014, encodeId=30921e400147c, content=<a href='/topic/show?id=ba713901132' target=_blank style='color:#2F92EE;'>#名人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39011, encryptionId=ba713901132, topicName=名人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52dd34624016, createdName=若水134, createdTime=Sat Jun 08 13:07:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424263, encodeId=1e001424263bf, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82929, encryptionId=94c182929d0, topicName=肿瘤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60943920553, createdName=lanyan20020087, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625630, encodeId=46ab162563085, content=<a href='/topic/show?id=1d813e2239c' target=_blank style='color:#2F92EE;'>#去世#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37223, encryptionId=1d813e2239c, topicName=去世)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cf720829073, createdName=psybestwish, createdTime=Thu Nov 15 13:07:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352562, encodeId=9e67352562b2, content=了解一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Nov 14 12:10:03 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352512, encodeId=611f3525127a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Nov 13 22:41:45 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352506, encodeId=c37b352506c6, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Nov 13 22:26:21 CST 2018, time=2018-11-13, status=1, ipAttribution=)]
    2018-11-13 天地飞扬

    了解一下,谢谢分享!

    0

相关资讯

期待医保、商保共同缓解肿瘤患者就医负担

健康险更好发展的出路之一,是把保险和医疗融为一体,即HMO模式。

肿瘤患者需警惕静脉血栓栓塞症

静脉血栓栓塞症(VTE)包括深静脉血栓(DVT)与肺栓塞(PE),已成为住院肿瘤患者死亡的第二大原因,仅次于肿瘤本身,堪称肿瘤患者的定时炸弹。肿瘤患者如果发生静脉血栓栓塞症,不仅增加治疗难度,降低患者的生活质量,减少生存预期,还会大幅增加住院时间与治疗费用。

血液肿瘤患者的福音 CAR-T疗法

CAR-T疗法,全称为Chimeric Antigen Receptor T Cell Immunotherapy,中文名为嵌合抗原受体T细胞免疫疗法。与其他免疫治疗技术一样,CAR-T技术也经历了漫长的发展过程,自1989年美国的ZeligEshhar教授首次提出CAR概念以来,CAR-T技术在经历29年的淬炼后,已从实验室走向临床,被业内人士认为是目前最具前景的肿瘤治疗方式之一。

肿瘤患者放化疗后口腔粘膜炎的处理

肿瘤化疗和放疗过程中都可能对快速增长的黏膜上皮细胞造成损伤,引发口腔黏膜炎和胃肠道黏膜炎。放化疗后口腔黏膜炎是指由于放射线电离辐射损伤或者化疗药物的应用引起免疫力下降,口腔内菌群失调,导致口腔软组织发生炎症病变,是肿瘤患者接受化疗过程中较常见,最痛苦的毒副作用之一。粘膜炎一般具有自愈性,一旦组织不受损伤,就开始愈合。黏膜损伤会在几天内自然地消失,一般在化疗后10~14天内完全愈合。

每年近50万肿瘤患者到海外看病!国家出手解决

近日,有媒体报道,根据某机构不完全统计显示,2017年中国到海外就医的人数已经突破60万人次,其中80%是癌症患者。更有市场预测,未来10年中国海外医疗市场潜力可能达到数百亿美元。

Ann Oncol:如何保证DPYD变异的肿瘤患者用药更安全?

2017年12月,发表在《Ann Oncol》的一项由荷兰科学家进行的研究,考察了如何用DPYD基因型指导的剂量个体化改善氟嘧啶疗法的患者安全性,并呼吁药物标签更新。